Profile data is unavailable for this security.
About the company
The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, China, and the United Kingdom. Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.
- Revenue in AUD (TTM)14.24m
- Net income in AUD-11.28m
- Incorporated2017
- Employees--
- LocationHydration Pharmaceuticals Co LtdLevel 2,, 6 Palmer Parade,, CremorneMELBOURNE 3121AustraliaAUS
- Websitehttps://hydralyte.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Imagion Biosystems Ltd | 1.94m | -6.32m | 926.81k | -- | -- | -- | -- | 0.4767 | -0.1975 | -0.1975 | 0.0604 | -0.1616 | 0.6283 | -- | 18.04 | -- | -204.15 | -77.35 | -- | -92.61 | -- | -- | -324.91 | -1,165.21 | -- | -10.76 | -- | -- | 152.07 | 31.06 | -27.19 | -- | 17.90 | -- |
Melodiol Global Health Ltd | 19.60m | -35.52m | 1.13m | -- | -- | -- | -- | 0.0574 | -7.64 | -11.29 | 4.73 | -0.5149 | 0.6874 | 4.35 | 10.62 | -- | -124.57 | -102.92 | -387.77 | -152.32 | 15.38 | -- | -181.22 | -348.92 | 0.1594 | -6.71 | 1.73 | -- | 210.13 | 94.60 | -62.47 | -- | -46.82 | -- |
Hydration Pharmaceuticals Co Ltd | 14.24m | -11.28m | 2.74m | -- | -- | -- | -- | 0.1927 | -0.045 | -0.045 | 0.0535 | -0.0133 | 1.49 | 1.56 | 6.38 | -- | -117.74 | -79.98 | -251.39 | -111.57 | 56.00 | 48.73 | -79.18 | -99.53 | 0.8282 | -4.39 | 2.42 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
Nutritional Growth Solutions Ltd | 3.98m | -3.95m | 3.34m | -- | -- | -- | -- | 0.839 | -0.1634 | -0.1634 | 0.1644 | -0.0837 | 2.08 | 2.36 | 33.46 | -- | -206.84 | -- | -- | -- | 22.36 | 42.47 | -99.30 | -152.30 | 0.0943 | -57.50 | -- | -- | 1.26 | 41.61 | 31.91 | -- | -- | -- |
Epsilon Healthcare Ltd | 7.21m | -5.93m | 7.21m | -- | -- | 0.7868 | -- | 0.9994 | -0.0198 | -0.0198 | 0.0241 | 0.0305 | 0.3839 | 17.94 | 2.73 | -- | -31.54 | -35.68 | -46.30 | -41.11 | 37.99 | 26.88 | -82.17 | -197.56 | 0.5237 | -9.28 | 0.2329 | -- | 29.36 | 30.99 | -43.77 | -- | 8.14 | -- |
Anatara Lifesciences Ltd | 0.00 | -1.45m | 9.26m | -- | -- | 6.72 | -- | -- | -0.0098 | -0.0098 | 0.00 | 0.0071 | 0.00 | -- | -- | -- | -93.91 | -76.37 | -126.61 | -88.90 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 28.27 | -- | -- | -- |
TrivarX Ltd | 893.31k | -1.24m | 9.60m | 4.00 | -- | 0.8705 | -- | 10.74 | -0.004 | -0.004 | 0.0027 | 0.0241 | 0.0935 | -- | -- | -- | -12.95 | -37.24 | -15.25 | -43.28 | 100.00 | 92.56 | -138.48 | -442.33 | -- | -91.05 | 0.0016 | -- | -6.99 | -26.39 | 59.71 | -- | 20.72 | -- |
Nyrada Inc | 3.40m | -1.39m | 10.39m | -- | -- | 2.06 | -- | 3.05 | -0.0081 | -0.0081 | 0.0209 | 0.0277 | 0.6147 | -- | -- | -- | -25.13 | -53.28 | -29.75 | -62.52 | -- | -- | -40.89 | -236.15 | -- | -- | 0.00 | -- | 115.55 | 46.42 | 82.12 | -- | -- | -- |
Firebrick Pharma Ltd | 14.52k | -1.18m | 10.96m | -- | -- | 4.67 | -- | 754.64 | -0.0066 | -0.0066 | 0.00008 | 0.012 | 0.0054 | -- | 0.0267 | -- | -43.64 | -98.70 | -51.22 | -109.33 | -156.89 | -- | -8,098.28 | -80,697.28 | 6.36 | -- | 0.00 | -- | 1,649.40 | -- | 82.71 | -- | -- | -- |
Althea Group Holdings Ltd | 30.37m | -32.06m | 12.16m | -- | -- | 38.84 | -- | 0.4004 | -0.0858 | -0.0858 | 0.0808 | 0.0008 | 0.8438 | 2.34 | 7.03 | -- | -89.06 | -37.78 | -167.97 | -47.13 | 60.70 | 53.83 | -105.54 | -94.47 | 0.4086 | -4.08 | 0.9466 | -- | 20.87 | 99.01 | -133.57 | -- | -25.27 | -- |
Holder | Shares | % Held |
---|---|---|
PURE Asset Management Pty Ltd.as of 25 May 2024 | 60.95m | 19.99% |
Regal Funds Management Pty Ltd.as of 20 Sep 2023 | 27.70m | 9.09% |
Gowing Bros. Ltd. (Investment Management)as of 03 Mar 2023 | 2.96m | 0.97% |